SCCF Sachem Q4 2025 earnings vastly beat analyst expectations with shares remaining flat in regular session trading Amgen Inc AMGN Stem Cell Therapy Leadership Meets Balanced NearTerm Valuation Dynamics Is SUPER HI HDL stock worth trading today